Genovate Biotechnology Co., Ltd. (TPEX:4130)

Genovate Biotechnology Revenue

Genovate Biotechnology had revenue of 131.31M TWD in the quarter ending March 31, 2025, a decrease of -5.78%. This brings the company's revenue in the last twelve months to 502.80M, down -6.25% year-over-year. In the year 2024, Genovate Biotechnology had annual revenue of 510.86M, down -3.34%.

• Revenue (ttm): 502.80M
• Revenue Growth: -6.25%
• P/S Ratio: 4.25
• Revenue / Employee: 2.63M
• Employees: 195
• Market Cap: 2.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.86M	-17.66M	-3.34%
Dec 31, 2023	528.51M	89.75M	20.46%
Dec 31, 2022	438.76M	4.51M	1.04%
Dec 31, 2021	434.25M	-38.47M	-8.14%
Dec 31, 2020	472.72M	6.97M	1.50%